Test Id : FUNSF
Fungitell, CSF
Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
For information, see Meningitis/Encephalitis Panel Algorithm.
Method Name
A short description of the method used to perform the test
Limulus Amebocyte Lysate (LAL) Pathway
NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Reporting Name
Lists a shorter or abbreviated version of the Published Name for a test
Aliases
Lists additional common names for a test, as an aid in searching
BDG
Beta D Glucan
Beta-D glucan
Beta-D-Glucan
Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
For information, see Meningitis/Encephalitis Panel Algorithm.
Specimen Type
Describes the specimen type validated for testing
CSF
Specimen Required
Defines the optimal specimen required to perform the test and the preferred volume to complete testing
Specimen Type: Spinal Fluid
Sources: CSF
Container/Tube: Sterile container
Specimen Volume: 2 mL
Collection Instructions: Collect 1-3 mL of spinal fluid (CSF) in a sterile container. Ship 2 mL frozen.
Special Instructions
Library of PDFs including pertinent information and forms related to the test
Specimen Minimum Volume
Defines the amount of sample necessary to provide a clinically relevant result as determined by the testing laboratory. The minimum volume is sufficient for one attempt at testing.
0.2 mL
Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected
Hemolysis | Mild reject; Gross reject |
Lipemia | Mild reject; Gross reject |
Icterus | Mild reject; Gross reject |
Other | NA |
Specimen Stability Information
Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
CSF | Frozen (preferred) | 30 days | |
Ambient | 4 days | ||
Refrigerated | 7 days |
Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
For information, see Meningitis/Encephalitis Panel Algorithm.
Clinical Information
Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
The Fungitell Beta-D Glucan assay is indicated for the presumptive diagnosis of invasive fungal disease through detection of elevated levels of (1,3)- Beta-D-glucan in serum. Normal human serum contains low levels of (1,3)- Beta-D glucan, typically 10 to 40 pg/mL, presumably from commensal yeasts present in the alimentary canal and gastrointestinal tract. However, (1,3)- Beta-D-glucan is sloughed from the cell walls during the life cycle of most pathogenic fungi. Thus, monitoring serum for evidence of elevated and rising levels of (1,3)- Beta-D-glucan provides a convenient surrogate marker for invasive fungal disease.
The Fungitell Beta - D Glucan assay detects (1,3) - Beta-D-glucan from the following pathogens: Candida spp., Acremonium, Aspergillus spp., Coccidioides immitis, Fusarium spp., Histoplasma capsulatum, Trichosporon spp., Sporothrix schenckii, Saccharomyces cerevisiae, and Pneumocystis jiroveci. The Fungitell Beta-D Glucan assay does not detect certain fungal species such as the genus Cryptococcus, which produces very low levels of (1,3) - Beta-D-glucan, nor the Zygomycetes, such as Absidia, Mucor, and Rhizopus, which are not known to produce (1,3) - Beta-D-glucan. Studies indicate Blastomyces dermatitidis is usually not detected due to little (1,3) - Beta-D-glucan produced in the yeast phase.
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
A reference range for specimens other than serum has not been established.
Interpretation
Provides information to assist in interpretation of the test results
The performance characteristics of the Fungitell assay in CSF have been determined by Eurofins Viracor; there are no established criteria for the interpretation of Fungitell results from CSF. Research studies have evaluated the use of the Fungitell assay in CSF during a fungal meningitis outbreak (J. Clin. Microbiol. 2013, 51(4):1285-1287).
PDF Report
Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) Performed
Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.
Monday through Saturday
Report Available
The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.
Performing Laboratory Location
Indicates the location of the laboratory that performs the test
Fees :
Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.
- Authorized users can sign in to Test Prices for detailed fee information.
- Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
- Prospective clients should contact their account representative. For assistance, contact Customer Service.
CPT Code Information
Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
CPT codes are provided by the performing laboratory.
CPT codes are provided by the performing laboratory.
87449
LOINC® Information
Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
FUNSF | Fungitell, CSF | Not Provided |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
FUNSF | Fungitell, CSF | 95072-5 |
Test Setup Resources
Setup Files
Test setup information contains test file definition details to support order and result interfacing between Mayo Clinic Laboratories and your Laboratory Information System.
Sample Reports
Normal and Abnormal sample reports are provided as references for report appearance.
SI Sample Reports
International System (SI) of Unit reports are provided for a limited number of tests. These reports are intended for international account use and are only available through MayoLINK accounts that have been defined to receive them.
Test Update Resources
Change Type | Effective Date |
---|---|
Test Changes - Transport Temperature | 2023-10-09 |